Cell-free plasma microRNAs that identify patients with glioblastoma
暂无分享,去创建一个
S. Kesari | D. Hoon | P. Hothi | Matias A. Bustos | Linh T. B. Tran | G. Barkhoudarian | R. Ramos | N. Rahimzadeh | Rebecca Gross | Linh T Tran | Amy Eisenberg | Yuki Takasumi | Suyeon Ryu | V. M. Renteria-Lopez | Charles Cobbs | Daniel F. Kelly | Daniel F Kelly | Amy A. Eisenberg | Victor M. Renteria-Lopez
[1] S. Murray,et al. Glioblastoma: clinical presentation, diagnosis, and management , 2021, BMJ.
[2] S. R. Benhabbour,et al. Glioblastoma Multiforme—A Look at the Past and a Glance at the Future , 2021, Pharmaceutics.
[3] B. Mroczko,et al. Molecular and Circulating Biomarkers of Brain Tumors , 2021, International journal of molecular sciences.
[4] G. Lippi,et al. Serum Exosomal microRNA-21, 222 and 124-3p as Noninvasive Predictive Biomarkers in Newly Diagnosed High-Grade Gliomas: A Prospective Study , 2021, Cancers.
[5] O. Chabre,et al. MicroRNA Therapeutics in Cancer: Current Advances and Challenges , 2021, Cancers.
[6] M. Mullins,et al. Clinical Applications of Magnetic Resonance Spectroscopy in Brain Tumors: From Diagnosis to Treatment. , 2021, Radiologic clinics of North America.
[7] T. Ochiya,et al. A novel combination of serum microRNAs for the detection of early gastric cancer , 2021, Gastric Cancer.
[8] M. Halushka,et al. miR-21: a non‐specific biomarker of all maladies , 2021, Biomarker research.
[9] Fan-En Yuan,et al. Circulating Tumor Cells for Glioma , 2021, Frontiers in Oncology.
[10] A. Morokoff,et al. Circulating Biomarkers for Glioma: A Review. , 2021, Neurosurgery.
[11] D. Hoon,et al. Assessment of Cell-Free microRNA by NGS Whole-Transcriptome Analysis in Cutaneous Melanoma Patients' Blood. , 2021, Methods in molecular biology.
[12] Lei Jin,et al. Serum miR-3180-3p and miR-124-3p may Function as Noninvasive Biomarkers of Cisplatin Resistance in Gastric Cancer. , 2020, Clinical laboratory.
[13] S. O’Day,et al. A Pilot Study Comparing the Efficacy of Lactate Dehydrogenase Levels Versus Circulating Cell-Free microRNAs in Monitoring Responses to Checkpoint Inhibitor Immunotherapy in Metastatic Melanoma Patients , 2020, Cancers.
[14] S. Gordon,et al. Disorders of synaptic vesicle fusion machinery , 2020, Journal of neurochemistry.
[15] Qiuyun Chen,et al. Exosomal miR‐3180‐3p inhibits proliferation and metastasis of non‐small cell lung cancer by downregulating FOXP4 , 2020, Thoracic cancer.
[16] T. Speed,et al. Serum microRNA is a biomarker for post-operative monitoring in glioma , 2020, Journal of Neuro-Oncology.
[17] Leon M Larcher,et al. Therapeutically Significant MicroRNAs in Primary and Metastatic Brain Malignancies , 2020, Cancers.
[18] S. O’Day,et al. Integrated Assessment of Circulating Cell-Free MicroRNA Signatures in Plasma of Patients with Melanoma Brain Metastasis , 2020, Cancers.
[19] A. Ciechanover,et al. Downregulation of the Ubiquitin-E3 Ligase RNF123 Promotes Upregulation of the NF-κB1 Target SerpinE1 in Aggressive Glioblastoma Tumors , 2020, Cancers.
[20] Yirizhati Aili,et al. Liquid biopsy in central nervous system tumors: the potential roles of circulating miRNA and exosomes. , 2020, American journal of cancer research.
[21] L. Qi,et al. ATP6L promotes metastasis of colorectal cancer by inducing epithelial‐mesenchymal transition , 2019, Cancer science.
[22] Zev A. Binder,et al. Clinical Utility of Plasma Cell-Free DNA in Adult Patients with Newly Diagnosed Glioblastoma: A Pilot Prospective Study , 2019, Clinical Cancer Research.
[23] L. Radová,et al. Cerebrospinal Fluid MicroRNA Signatures as Diagnostic Biomarkers in Brain Tumors , 2019, Cancers.
[24] C. Lim,et al. Prospective Molecular Profiling of Circulating Tumor Cells from Patients with Melanoma Receiving Combinatorial Immunotherapy. , 2019, Clinical chemistry.
[25] D. Glavač,et al. Dynamic Expression of 11 MiRNAs in 83 Consecutive Primary and Corresponding Recurrent Glioblastoma: Correlation to Treatment, Time to Recurrence, Overall Survival and MGMT Methylation Status , 2018, Radiology and oncology.
[26] D. Hoon,et al. Multiplex Gene Profiling of Cell-Free DNA in Patients With Metastatic Melanoma for Monitoring Disease. , 2018, JCO precision oncology.
[27] Beiying Liu,et al. Silencing of vacuolar ATPase c subunit ATP6V0C inhibits the invasion of prostate cancer cells through a LASS2/TMSG1-independent manner. , 2017, Oncology reports.
[28] A. Silahtaroglu,et al. The DLGAP family: neuronal expression, function and role in brain disorders , 2017, Molecular Brain.
[29] G. Reifenberger,et al. The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary , 2016, Acta Neuropathologica.
[30] A. Keller,et al. Distribution of miRNA expression across human tissues , 2016, Nucleic acids research.
[31] A. Kaye,et al. Dynamics of circulating hypoxia-mediated miRNAs and tumor response in patients with high-grade glioma treated with bevacizumab. , 2016, Journal of neurosurgery.
[32] Ailin Li,et al. Plasma specific miRNAs as predictive biomarkers for diagnosis and prognosis of glioma , 2012, Journal of Experimental & Clinical Cancer Research.
[33] Shi-zhuo Wang,et al. Reduced expression of tissue factor pathway inhibitor-2 contributes to apoptosis and angiogenesis in cervical cancer , 2012, Journal of experimental & clinical cancer research : CR.
[34] Dong Ryul Lee,et al. The hsa-miR-5739 modulates the endoglin network in endothelial cells derived from human embryonic stem cells. , 2011, Biochemical and biophysical research communications.
[35] E. Kroh,et al. Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma , 2011, Proceedings of the National Academy of Sciences.
[36] Chao Li,et al. Human transcriptional interactome of chromatin contribute to gene co-expression , 2010, BMC Genomics.
[37] Momiao Xiong,et al. Investigation gene and microRNA expression in glioblastoma , 2009, 2009 International Joint Conference on Bioinformatics, Systems Biology and Intelligent Computing.
[38] J. Manson,et al. Prospective Study of , 2007 .
[39] James L. Buescher,et al. Tau‐tubulin kinase 1 (TTBK1), a neuron‐specific tau kinase candidate, is involved in tau phosphorylation and aggregation , 2006, Journal of neurochemistry.
[40] P. McLaughlin. Diagnosis treatment. , 2000, British dental journal.
[41] Robert C. Wolpert,et al. A Review of the , 1985 .
[42] J. Sneep,et al. With a summary , 1945 .